The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Real-world evidence of response to 177Lu-DOTATATE peptide receptor radionuclide therapy (PRRT) based on primary and metastatic sites in patients (pts) with neuroendocrine tumor (NET).
 
Yash Shah
No Relationships to Disclose
 
Ian Tobal
No Relationships to Disclose
 
Sameera Shuaibi
No Relationships to Disclose
 
Dhaval Patel
No Relationships to Disclose
 
Allen Zhou
No Relationships to Disclose
 
Meena Mishra
No Relationships to Disclose
 
Susan Olet
No Relationships to Disclose
 
Lingling Du
Consulting or Advisory Role - AstraZeneca; BeOne Medicines; Boston Scientific; Bristol-Myers Squibb; Exelixis; Incyte; Ipsen; Merus; Pfizer
Speakers' Bureau - AstraZeneca; Exelixis; Ipsen